Abstract
Alzheimer’s disease (AD), the most common type of adult-onset dementia [65], has been analyzed at several levels (Table 1; Fig. 1): regional distributions of disease; neuronal populations/systems at risk; abnormalities occurring in individual nerve cells; and molecular pathology of cellular constituents. These investigations have demonstrated that AD selectively involves specific parts of brain, certain transmitter systems, and components of the neuronal cytoskeleton. Dysfunction/death of at-risk populations of neurons in brainstem, basal forebrain, amygdala, hippocampus, and neocortex leads to impairments in memory, language, visual-spatial perceptions, etc. Human studies are complemented by investigations in animals that are essential for analyzing mechanisms, evolutions, and consequences of disorders in certain neuronal populations, for studying the cellular and molecular dynamics of disease processes, and for relating these processes to the clinical expressions of illness. This review discusses some new information derived from neuropathological and neurobiological studies of AD and of animal models sharing features with the human disease (Table 1; Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aigner T, Aggleton J, Mitchell SJ, Price D, DeLong M, Mishkin M (1983) Effects of scopolamine on recognition memory in monkeys after ibotenic acid injections into the nucleus basalis of Meynert. Soc Neurosci Abstr 9: 826
Aigner T, Mitchell S, Aggleton J, DeLong M, Struble R, Wenk G, Price D, Mishkin M (1984) Recognition deficit in monkeys following neurotoxic lesions of the basal forebrain. Soc Neurosci Abstr 10: 386
Anderton BH, Breinburg D, Downes MJ, Green PJ, Tomlinson BE, Ulrich J, Wood JN, Kahn J (1982) Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 298: 84–86
Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans, and Korsakoff’s disease. Acta Neuropathol(Berl) 61: 101–108
Ball MJ (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A qualitative study. Acta Neuropathol (Berl) 37: 111 – 118
Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417
Beal MF, Mazurek MF, Tran VT, Chattha G, Bird ED, Martin JB (1985) Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer’s disease. Science 229: 289–291
Bizzi A, Crane RC, Autilio-Gambetti L, Gambetti P (1984) Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci 4: 722–731
BondareffW, Mountjoy CQ, Roth M (1982) Loss of neurons or origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32: 164–168
Bowen DM (1983) Biochemical assessment of neurotransmitter and metabolic dysfunction and cerebral atrophy in Alzheimer’s disease. Biological aspects of Alzheimer’s Disease. Banbury Rep 15: 219–231
Brun A (1983) An overview of light and electron microscopic changes. In: Reisberg B (ed) Alzheimer’s disease. The Free Press, New York, pp 37–47
Buell SJ, Coleman PD (1981) Quantitative evidence for selective dendritic growth in normal human aging but not in senile dementia. Brain Res 214: 23–41
Cleveland DW, Sullivan KF (1985) Molecular biology and genetics of tubulin. Annu Rev Biochem 54: 331–365
Colon EJ (1973) The cerebral cortex in presenil dementia. A quantitative analysis. Acta Neuropathol (Berl) 23: 281–290
Cork LC, Altschuler RJ, Struble RG, Casanova MF, Price DL, Sternberger N, Sternberger L (1985) Changes in the distribution of phosphorylated neurofilaments in Alzheimer’s disease. J Neuropathol Exp Neurol 44: 368
Cork LC, Sternberger NH, Sternberger LA, Casanova MF, Struble RG, Price DL (1986) Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer’s disease. J Neuropathol Exp Neurol
Coyle JT, Price DL, DeLong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1190
Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE (1981) Reduced dopamine-ß-hydroxylase activity in Alzheimer’s disease. Br Med J 282: 93–94
Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288: 279–280
Davis RT(1978) Old monkey behavior. Exp Gerontol 13:237–250
Gambetti P, Shecket G, Ghetti B, Hirano A, Dahl D (1983) Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Neurol 42: 69–79
Geisler N, Kaufmann E, Fischer S, Plessmann U, Weber K (1983) Neurofilament architecture combines structural principles of intermediate filaments with carboxyterminal extensions increasing in size between triplet proteins. EMBO J 2: 1295–1302
Gibson PH, Tomlinson BE (1977) Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer’s disease. J Neurol Sci 33: 199–206
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885–890
Goldman JE (1983) The association of actin with Hirano bodies. J Neuropathol Exp Neurol 42: 146–152
Greenamyre JT, Penney JB, Young AB, D’Amato CJ, Hicks SP, Shoulson I (1985) Alterations in L-glutamate binding in Alzheimer’s and Huntington’s diseases. Science 227: 1496–1499
Hedreen JC, Struble RG, Whitehouse PJ, Price DL (1984) Topography of the magnocellular basal forebrain system in human brain. J Neuropathol Exp Neurol 43: 1–21
Hirano A, Zimmerman HM (1962) Alzheimer’s neurofibrillary changes. A topographic study. Arch Neurol 7: 227–242
Hirano A, Dembitzer HM, Kurland LT, Zimmerman HM (1968) The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and “rod-like” structures as seen in amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol 27: 167–182
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168–1170
Jamada M, Mehraein P (1968) Verteilungsmuster der senilen Veränderungen im Gehirn. Die Beteiligung des limbischen Systems bei hirnatrophischen Prozessen des Seniums und bei Morbus Alzheimer. Arch Psychiatr Z Neurol 211: 308–324
Kemper TL (1983) Organization of the neuropathology of the amygdala in Alzheimer’s disease. Biological aspects of Alzheimer’s Disease. Banbury Rep 15: 31–35
Kidd M (1963) Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature 197: 192–193
Kitt CA, Price DL, Struble RG, Cork LC, Wainer BH, Becher MW, Mobley WC (1984) Evidence for cholinergic neurites in senile plaques. Science 226: 1443–1445
Kitt CA, Struble RG, Cork LC, Mobley WC, Walker LC, Joh TH, Price DL (in press) Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates. Neuroscience 16:691–699
Lewis SA, Cowan NJ (in press) Temporal expression of mouse GFAP mRNA studied by a rapid in situ hybridization procedure. J Neurochem
Mash DC, Flynn DD, Potter LT (1985) Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer’s disease and experimental cholinergic denervation. Science 228: 1115–1117
Mesulam MM, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214: 170–197
Morrison JH, Rogers J, Scherr S, Benoit R, Bloom FE (1985) Somatostatin immunoreactivity in neuritic plaques of Alzheimer’s patients. Nature 314: 90–94
Mountjoy CQ, Roth M, Evans NJR, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4: 1–11
Nukina N, Ihara Y (1983) Immunocytochemical study on senile plaques in Alzheimer’s disease. II. Abnormal dendrites in senile plaques as revealed by antimicrotubule-associated proteins (MAPs) immunostaining. Proc Jpn Acad 59: 288–292
Perl DP, Brody AR (1980) Alzheimer’s disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208: 297–299
Perry EK, Perry RH (1985) New insights into the nature of senile (Alzheimer-type) plaques. Trends Neurosci 8: 301–303
Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE (1984) Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer’s disease: comparisons with Parkinson’s disease. Neurosci Lett 51: 353–357
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459
Perry RH, Candy JM, Perry EK (1983) Some observations and speculations concerning the cholinergic system and neuropeptides in Alzheimer’s disease. Biological aspects of Alzheimer’s Disease. Banbury Rep 15: 351–361
Powers JM, Schlaepfer WW, Willingham MC, Hall BJ (1981) An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J Neuropathol Exp Neurol 40: 592–612
Price DL, Cork LC, Stuble RG, Kitt CA, Price DL Jr, Lehmann J, Hedreen JC (1985) Neuropathological, neurochemical, and behavioral studies of the aging nonhuman primate. In: Davis RT, Leathers CW (eds) Behavior and pathology of aging in Rhesus monkeys. Alan R. Liss, New York
Price DL, Whitehouse PJ, Struble RG, Coyle JT, Clark AW, DeLong MR, Cork LC, Hedreen JC (1982) Alzheimer’s disease and Down’s syndrome. Ann NY Acad Sci 396: 145–164
Price DL, Whitehouse PJ, Struble RG, Price DL Jr, Cork LC, Hedreen JC, Kitt CA (1983) Basal forebrain cholinergic neurons and neuritic plaques in primate brain. Biological Aspects of Alzheimer’s Disease. Banbury Rep 15: 65–77
Probst A, Basler V, Bron B, Ulrich J (1983) Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res 268: 249–254
Probst A, Ulrich J, Heitz PU (1982) Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. Acta Neuropathol (Berl) 57: 75–79
Roberts GW, Crow TJ, Polak JM (1985) Location of neuronal tangles in somatostatin neurones in Alzheimer’s disease. Nature 314: 92–94
Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20: 373–377
Saper CB, German DC, White CL III (1985) Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer’s type: possible role in cell loss. Neurology 35: 1089–1095
Scheibel AB (1979) Dendritic changes in senile and presenile dementias. In: Katzman R (ed) Congenital and acquired cognitive disorders. Raven, New York, pp 107–124
Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40: 503–509
Struble RG, Cork LC, Whitehouse PJ, Price DL (1982) Cholinergic innervation in neuritic plaques. Science 216: 413–415
Struble RG, Hedreen JC, Cork LC, Price DL (1984) Acetylcholinesterase activity in senile plaques of aged macaques. Neurobiol Aging 5: 191–198
Struble RG, Kitt CA, Walker LC, Cork LC, Price DL (1984) Somatostatinergic neurites in senile plaques of aged non-human primates. Brain Res 324: 394–396
Struble RG, Lehmann J, Mitchell SJ, Cork LC, Coyle JT, Price DL, DeLong MR, Antuono PG (in press) Cortical cholinergic innervation: distribution and source in monkeys. In: Hanin I (ed) Dynamics of cholinergic function. Plenum, New York
Struble RG, Powers RE, Casanova MF, Kitt CA, O’Connor DT, Price DL (1985) Multiple transmitter-specific markers in senile plaques in Alzheimer’s disease. J Neuropathol Exp Neurol 44: 325
Struble RG, Price DL Jr, Cork LC, Price DL (1985) Senile plaques in cortex of aged normal monkeys. Brain Res 361: 267–275
Tomlinson BE, Kitchener D (1972) Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol 106: 165–185
Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205–242
Tomlinson BE, Irving D, Blessed G (1981) Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 49: 419–428
Troncoso JC, Hoffman PN, Griffin JW, Hess-Kozlow KM, Price DL (1985) Aluminum intoxication: a disorder of neurofilament transport in motor neurons. Brain Res 342: 172–175
Troncoso JC, Price DL, Griffin JW, Parhad IM (1982) Neurofibrillary axonal pathology in aluminum intoxication. Ann Neurol 12: 278–283
Walker LC, Kitt CA, Struble RG, Schmechel DE, Oertel WH, Cork LC, Price DL (1985) Glutamic acid decarboxylase-like immunoreactivity in senile plaques. Neurosci Lett 59: 165–169
Whitehouse PJ, Martino AM, Antuono PG, Coyle JT, Price DL, Kellar KJ (1985) Reductions in nicotinic receptors measured using [3H] acetylcholine in Alzheimer’s disease. Soc Neurosci Abstr 11: 134
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237–1239
Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia. A quantitative study. J Neurol Sci 56: 343–356
Wilcock GK, Esiri MM, Bowen DM, Smith CCT(1982) Alzheimer’s disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57: 407–417
Winblad B, Adolfsson R, Carlsson A, Gottfries C-G (1982) Biogenic amines in brains of patients with Alzheimer’s disease. In: Corkin S, Davis KL, Growdon JH, Usdin E, Wurtman RJ (eds) Alzheimer’s disease: a report of progress in research. Raven, New York, pp 25–33 (Aging, vol 19 )
Wisniewski HM, Terry RD (1973) Reexamination of the pathogenesis of the senile plaque. In: Zimmerman HM (ed) Progress in neuropathology, vol 2. Grune and Stratton, New York, pp 1–26
Wisniewski HM, Sturman JA, Shek JW (1980) Aluminum chloride induced neurofibrillary changes in the developing rabbit: a chronic animal model. Ann Neurol 8: 479–490
Yamamoto T, Hirano A (1985) Nucleus raphe dorsalis in Alzheimer’s disease: neurofibrillary tangles and loss of large neurons. Ann Neurol 17: 573–577
Yates CM, Simpson J, Gordon A, Maloney AFJ, Allison Y, Ritchie IM, Urquhart A (1983) Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down’s syndrome. Brain Res 280: 119–126
DeSouza EB, Whitehouse PJ, Kuhar, MJ, Price DL, Vale WW (1986) Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer’s disease. Nature 319: 593–595
Powers RE, Struble RG, Casanova MF, O’Connor DT, Kitt CA, Price DL (in press) Hippocampal anatomy and structural abnormalities of noradrenergic systems in aging and in Alzheimer’s disease. Neuroscience
Price DL, Altschuler RJ, Struble RG, Casanova MF, Cork LC, Murphy DB (in press) Sequestration of tubulin in neurons in Alzheimer’s disease. Brain Res
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Price, D.L., Struble, R.G., Cork, L.C., Whitehouse, P.J., Kitt, C.A., Troncoso, J.C. (1986). Classical and Modern Neuropathological Approaches to Alzheimer’s Disease. In: Poeck, K., Freund, HJ., Gänshirt, H. (eds) Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70007-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-70007-1_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70009-5
Online ISBN: 978-3-642-70007-1
eBook Packages: Springer Book Archive